PRLD · Prelude Therapeutics Inc
$5.55
+0.19 (+3.54%)
At close · Aug 14
Market Cap
$442.91M
Shares
79.80M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-03-10 | Citizens Life Sciences Conference 2026 | Conference |
| 2025-11-12 | Prelude Therapeutics Third Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-06-11 | Goldman Sachs 46th Annual Global Healthcare Conference | Conference |
| 2025-06-05 | 2025 Jefferies Global Healthcare Conference | Conference |
| 2025-05-07 | Citizens Life Sciences Conference | Conference |
| 2025-03-11 | Barclays 27th Annual Global Healthcare Conference | Conference |
| 2024-12-02 | The Citizens JMP Hematology and Oncology Summit | Event |
| 2024-09-13 | PRT3789 Phase 1 Interim Clinical Data Update from 2024 ESMO Congress | Event |
Source: https://preludetx.com/investors/
Key facts
CIK
1678660
CUSIP
74065P101
13F (30d)
78 filings
78 filers
Visit website
Investor relations